Latest AI and machine learning research in dementia for healthcare professionals.
Postmortem neuropathological examination, while the gold standard for diagnosing neurodegenerative diseases, often relies on limited regional sampling that may miss critical areas affected by Alzheimer's disease and related disorders. Ultra-high resolution postmortem MRI can help identify regions that fall outside the diagnostic sampling criteria for additional histopathologic evaluation. However,...
BACKGROUND: The impact of high body mass index (BMI) states and associated proteomic factors on brain ageing and Alzheimer's disease (AD) remains unclear.
Early detection of Alzheimer's disease (AD) remains a formidable clinical challenge, but emerging blood-based assays show promise for identifying at-r...
Alzheimer's Disease (AD) is the most prevalent neurodegenerative disorder, characterized by progressive cognitive decline. Early and accurate diagnosi...
Alzheimer's disease (AD) is a devastating neurological disorder that affects humans and is a major contributor to dementia. It is characterized by cog...
BACKGROUND: Alzheimer's disease (AD) begins years before symptoms appear, making early detection essential. The medial temporal lobe (MTL) is one of t...
BACKGROUND: The NeuroArtP3 (NET-2018-12366666) is a multicenter study funded by the Italian Ministry of Health. The aim of the project is to identify ...
BACKGROUND & AIMS: Internet use among older adults may reduce the risk of dementia, but it remains unknown how the effects vary across individuals. Th...
Alzheimer's disease (AD) is a progressive neurodegenerative disorder that often begins decades before clinical symptoms manifest. Early detection rem...
Mild cognitive impairment (MCI) represents an initial phase of memory or other cognitive function decline and is viewed as an intermediary stage betwe...
BackgroundCognitive decline in Alzheimer's disease (AD) often includes speech impairments, where subtle changes may precede clinical dementia onset. A...
BackgroundAlzheimer's disease (AD), marked by progressive memory loss and cognitive decline, poses diagnostic challenges due to its multifactorial nat...
Alzheimer's disease (AD) is a neurodegenerative disorder that severely impairs cognitive function across various age groups, ranging from early to la...
PURPOSE OF REVIEW: This review explores the use of brain age estimation from MRI scans as a biomarker of brain health. With disorders like Alzheimer's...
Alzheimer's disease (AD) and atherosclerosis (AS) are two interacting diseases mostly affecting aged adults. AD is characterized by the deposition of ...
MRI brain scans alone are not a definitive measure of dementia. Deep-learning algorithms (DLA) and professional human opinion are necessary for diagno...
BACKGROUND: Alzheimer's disease (AD) is a severe neurodegenerative disorder, yet its molecular mechanisms remain incompletely understood. It is known ...
BACKGROUND: At present, the world is in the background of severe aging population challenges. Mild cognitive impairment (MCI), an intermediate state b...
OBJECTIVE: Cortical regions such as parietal area H (PH) and the fundus of the superior temporal sulcus (FST) are involved in higher visual function a...
Alzheimer's disease (AD), the most common form of dementia, is marked by cognitive decline and amyloid-beta (Aβ) plaque deposition in the brain. Micro...